Surgeons Performing Euthanasia by Organ Removal: A Controversial Proposal

euthanasia organ donation bioethics

Quick Look

A proposal called "Death by Organ Donation" suggests surgeons could remove organs from euthanasia patients while alive, making organs more viable for transplant.
This idea, supported by some bioethicists, faces strong opposition due to ethical concerns and potential damage to trust in end-of-life care and organ donation systems.

AI-generated summary

Font size

A proposal called "Death by Organ Donation" suggests surgeons could remove organs from euthanasia patients while alive, making organs more viable for transplant. This idea, supported by some bioethicists, faces strong opposition due to ethical concerns and potential damage to trust in end-of-life care and organ donation systems.

Read the full article on NPR News

Michigan is experiencing a significant outbreak of cyclosporiasis, a diarrhea-causing illness, with over 700 cases reported since June 22. Despite 36 hospitalizations, the source of the parasitic infection remains unidentified, prompting a large-scale investigation involving state and federal health agencies.

Ars Technica

Developing·1d ago

Study Reveals High Prevalence of Red Meat Allergy Antibody, Raising Diagnostic Concerns

A new study found up to 30% of people in some US regions carry the antibody linked to a red meat allergy triggered by tick bites, far exceeding the estimated number of diagnosed cases. This suggests widespread asymptomatic sensitization and raises concerns about overdiagnosis.

Ars Technica

Developing·1d ago

How Scientists Identify Potential Pandemic Viruses

Scientists are developing methods to predict which newly discovered viruses could cause public health emergencies. By analyzing historical data on RNA viruses, transmissibility, and disease severity, researchers aim to identify potential pandemic threats like "disease X" before they spread widely.

Ars Technica

Developing·1d ago

New Treatments and Prevention Methods Tested in DRC and Uganda Ebola Outbreak

Over 50 days into the Ebola outbreak in DRC and Uganda, clinical trials are underway for new treatments against the rarer Bundibugyo virus. Two drugs, remdesivir and MBP-134, are being tested for treatment, while obeldesivir is being studied for post-exposure prevention. The trials face challenges including ongoing conflict and community mistrust.

NPR News

Surgeons Performing Euthanasia by Organ Removal: A Controversial Proposal

Quick Look

Related Topics

Related Stories

Michigan Faces Largest Cyclospora Outbreak in State History

The FDA Panel Weighs In on Trendy Peptide Therapies

Michigan Sees Exploding Diarrhea Outbreak With No Clear Source

Study Reveals High Prevalence of Red Meat Allergy Antibody, Raising Diagnostic Concerns

How Scientists Identify Potential Pandemic Viruses

New Treatments and Prevention Methods Tested in DRC and Uganda Ebola Outbreak